China

ZEISS announces NMPA approval in China for powerful ophthalmic microscopes, enhancing surgical visualisation

The ZEISS ARTEVO 750 ophthalmic microscope is another breakthrough in ZEISS's ophthalmic surgical microscope family that made its Chinese debut at the 2025 China International Import Expo (CIIE)...

Zylox-Tonbridge to Acquire Germany’s Optimed in Global Expansion Push

Builds an integrated global commercialisation platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide...

WORK Medical Grants East China Distribution Rights for AI-Automated Blood Cell Morphology Analyzer

The collaboration is expected to accelerate market access and drive large-scale commercialisation of the new product...

Everest Medicines Announces Commercialisation Service Agreement and License Agreement with Hasten

The two agreements are expected to create significant financial and strategic synergies...

China Gold Irradiation Introduces IBA’s sustainable X-ray irradiation technology

The Jianxing centre in East China will be the first CGI centre to install X-ray technology...

Singleron's Matrix NEO Receives Class II Medical Device Approval for Automated Single Cell Analysis

Matrix NEO is the world's first automated single-cell analysis platform to achieve medical device clearance, marking a milestone in bringing single-cell sequencing from research laboratories into clinical practice...

CoolMPS Brings a New Dimension to Sequencing

The collaboration enables MGI to leverage Swiss Rockets’ strong R&D capabilities and established presence in Europe and the U.S. to commercialise CoolMPS™...

China Launches Magnetic Resonance Platform for Brain-Computer Interface Research

It enables non-invasive, high-resolution in vivo analysis of the entire brain, significantly improving precision in both space and time...

Fangzhou’s XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations

The successful filing of the XJ LLM represents a milestone in Fangzhou’s AI-enabled chronic disease management ecosystem...